Lv3
400 积分 2021-11-07 加入
GPC3-IL7-CCL19-CAR-T primes immune microenvironment reconstitution for hepatocellular carcinoma therapy
6小时前
已完结
Bile acids activate cancer-associated fibroblasts and induce an immunosuppressive microenvironment in cholangiocarcinoma
30天前
已完结
Interpretable multimodal radiopathomics model predicting pathological complete response to neoadjuvant chemoimmunotherapy in esophageal squamous cell carcinoma
2个月前
已完结
Medical multimodal multitask foundation model for lung cancer screening
2个月前
已完结
Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data
3个月前
已完结
Optimizing CAR T cell therapy for solid tumours: a clinical perspective
5个月前
已完结
Current status of chimeric antigen receptor T cell therapy and its exhaustion mechanism
5个月前
已完结
Novel technologies for improving the safety and efficacy of CAR-T cell therapy
5个月前
已完结
Metabolic challenges and interventions in CAR T cell therapy
5个月前
已完结
Tuning CAR T-cell therapies for efficacy and reduced toxicity
5个月前
已关闭
皖公网安备34019202002308
